Relapsing polychondritis: What's new in 2017?

[Relapsing polychondritis: What's new in 2017?] Rev Med Interne. 2017 Sep 07;: Authors: Dion J, Leroux G, Mouthon L, Piette JC, Costedoat-Chalumeau N Abstract Relapsing polychondritis (RP) is a rare condition characterized by recurrent inflammation of cartilaginous tissue and systemic manifestations. Data on pathophysiology are scarce and suggest an autoimmune mechanism. Recently, the possibility of dividing patients with RP into three distinct clinical phenotypes has been suggested: the hematological form representing less than 10% of patients, essentially older men with associated myelodysplasia and poor prognosis, the respiratory form representing about 25% of patients with predominant tracheobronchial involvement, and the mild and most frequent form, representing 65% of patients, with a good prognosis. Recent data on survival shows an improvement of overall prognosis compared to historical series. Reported poor prognosis factors are male gender, associated haemopathies and cardiac involvement. Few recent series suggest an interest for positron emission tomography for the diagnosis and the follow-up of treatment. Due to the lack of randomized therapeutic trial, treatment remains empirical and is mainly based on oral corticosteroids sometimes associated with immunosuppressive agents. The use of biologic agents has recently been reported in small retrospective series with different outcome. Finally, some selected patients with mild and occasional periphe...
Source: Revue de Medecine Interne - Category: Internal Medicine Tags: Rev Med Interne Source Type: research

Related Links:

ConclusionAutoimmune diseases were present in 26% of patients. One-third of patients with anterior necrotizing scleritis or posterior scleritis experienced decreased vision, mostly due to secondary glaucoma and optic neuritis. Therefore, controlling intraocular pressure by methods such as administration of steroid-sparing immunosuppressive medication and appropriate treatment for posterior scleritis are essential for scleritis treatment.
Source: Japanese Journal of Ophthalmology - Category: Opthalmology Source Type: research
International Journal of Dermatology, EarlyView.
Source: International Journal of Dermatology - Category: Dermatology Authors: Source Type: research
Clinical and Experimental Dermatology, EarlyView.
Source: Clinical And Experimental Dermatology - Category: Dermatology Authors: Source Type: research
Journal Name: Drug Metabolism and Personalized Therapy Issue: Ahead of print
Source: Drug Metabolism and Personalized Therapy - Category: Drugs & Pharmacology Source Type: research
New England Journal of Medicine,Volume 378, Issue 18, Page 1715-1715, May 2018.
Source: New England Journal of Medicine - Category: Internal Medicine Authors: Source Type: research
PMID: 29760256 [PubMed - in process]
Source: Canadian Family Physician Medecin de Famille Canadien - Category: Primary Care Authors: Tags: Can Fam Physician Source Type: research
Journal Name: Drug Metabolism and Personalized Therapy Volume: 33 Issue: 2 Pages: 105-108
Source: Drug Metabolism and Personalized Therapy - Category: Drugs & Pharmacology Source Type: research
Relapsing polychondritis (RP) is an uncommon immune-related disease with unknown causes. It is characterized by inflammation of cartilaginous or non-cartilaginous structures, such as the ears, nose, respirator...
Source: BMC Neurology - Category: Neurology Authors: Tags: Case report Source Type: research
Annals of the American Thoracic Society,Volume 15, Issue 3, Page 290-292, March 2018.
Source: Annals of the American Thoracic Society - Category: Respiratory Medicine Authors: Source Type: research
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Colchicine | Colcrys | Corticosteroid Therapy | Hematology | History of Medicine | Internal Medicine | PET Scan | Polychondritis | Respiratory Medicine